Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers

作者
Na Zhang,Zhiyuan Jing,Jie Song,Qiyue Liang,Yuxue Xu,Zhaowei Xu,Longping Wen,Pengfei Wei
出处
期刊:Biomolecules [Multidisciplinary Digital Publishing Institute]
卷期号:15 (6): 763-763 被引量:11
标识
DOI:10.3390/biom15060763
摘要

Mutations in the p53 gene are frequently observed in various cancers, prompting the initiation of efforts to restore p53 function as a therapeutic approach several decades ago. Nevertheless, only a limited number of drug development initiatives have progressed to late-stage clinical trials, and to date, no p53-targeted therapies have received approval in the USA or Europe. This situation can be attributed primarily to the characteristics of p53 as a nuclear transcription factor, which lacks the conventional features associated with drug targets and has historically been considered "undruggable". In recent years, however, several promising strategies have emerged, including the enhanced iterations of previous approaches and novel techniques aimed at targeting proteins that have traditionally been considered undruggable. There is a growing interest in small molecules that can restore the tumor-suppressive functions of mutant p53 proteins, and the development of drugs specifically designed for particular p53 mutation types is currently underway. Other approaches aim to deplete mutant p53 or exploit vulnerabilities associated with its expression. Additionally, genetic therapy strategy and approaches have rekindled interest. Advances in mutant p53 biology, compound mechanisms, treatment modalities, and nanotechnology have opened up new avenues for p53-based therapies. However, significant challenges remain in clinical development. This review reassesses the progress in targeting p53-mutant cancers, discusses the obstacles in translating these approaches into effective therapies, and highlights p53-based therapies via nanotechnology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hhh发布了新的文献求助10
刚刚
Davin_ji完成签到 ,获得积分10
刚刚
星辰大海的应助被wwwwwl采纳,获得10
1秒前
1秒前
2秒前
2秒前
3秒前
椰子鸡完成签到 ,获得积分10
3秒前
3秒前
3秒前
Charles完成签到,获得积分10
4秒前
4秒前
4秒前
fantasy的应助被隔岸采纳,获得10
4秒前
芽卉完成签到 ,获得积分10
5秒前
爆米花的应助被鼻毛好胜采纳,获得10
5秒前
乐乐的应助被111采纳,获得10
6秒前
WZJ发布了新的文献求助30
6秒前
chaoqi完成签到,获得积分10
7秒前
CipherSage的应助被Leonard采纳,获得10
7秒前
Danny完成签到,获得积分20
7秒前
8秒前
YANG完成签到,获得积分10
8秒前
哈哈哈发布了新的文献求助10
9秒前
颜玖笙发布了新的文献求助10
10秒前
hhh完成签到,获得积分20
11秒前
暴龙战士发布了新的文献求助10
11秒前
12秒前
郭啦啦啦啦完成签到 ,获得积分10
12秒前
陆地完成签到,获得积分10
14秒前
16秒前
酷波er的应助被开朗紫采纳,获得10
16秒前
鼻毛好胜发布了新的文献求助10
16秒前
泍泍完成签到 ,获得积分10
17秒前
波波子发布了新的文献求助20
17秒前
自然的赛凤完成签到,获得积分20
18秒前
下雨之后完成签到 ,获得积分10
19秒前
19秒前
DYL完成签到,获得积分10
20秒前
SciGPT的应助被彩色的明雪采纳,获得10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181498
求助须知:如何正确求助?哪些是违规求助? 9571421
关于积分的说明 21817968
捐赠科研通 7777967
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479552